Biocon
Plenty of catalysts for Biocon over the next few months, say analysts
Biocon eyes international markets to supply Itolizumab for Covid-19 therapy
Biocon hits new high on DGCI nod to market Itolizumab for Covid treatment
Biocon's drug Itolizumab gets regulator nod to treat Covid-19 patients
Drug controller approves Biocon's psoriasis drug for emergency Covid-19 use

Pharma shares gain; Biocon, Granules hit record highs, Sun Pharma up 3%
Biocon to invest $200 million on capital expenditure in current fiscal
Biocon ties up with DKSH to distribute 7 products in Singapore, Thailand
Biocon gets a shot in the arm with FDA approval for insulin glargine
Biocon's Kiran Mazumdar-Shaw named EY World Entrepreneur of 2020

Biocon MD Kiran Mazumdar-Shaw named EY World Entrepreneur Of The Year
Biocon rallies 6%, hits record high on favourable ruling from US PTAB
Biocon gets DCGI nod for CytoSorb device to treat Covid-19 patients
Logging in with facemasks: Offices look different as staff returns to work
Will invest Rs 2k cr in small molecules segment in 3-4 yrs: Biocon CEO & MD
Biocon shares slump over 4% as profit declines 42% in March quarter
MARKET WRAP: Indices end flat, Sensex slips 25 pts; financials, autos fall
Market Ahead, May 11: Top factors that could guide markets this week
Mumbai docs try Biocon and Roche's biologic drugs on critical Covid cases
MSCI India rebalancing to stoke FPI inflows to the tune of Rs 1,900 cr